Acase of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR-tyrosine kinase inhibitors with MET amplification and epithelial-to-mesenchymal transition

OncoTargets and Therapy

Volumn 8, Issue , 2015, Pages 783-787

  Miyoshi, Seigo ^a   Kato, Takahide ^a   Katayama, Hitoshi ^a   Ito, Ryoji ^a   Mizuno, Yosuke ^a   Okura, Takafumi ^a   Higaki, Jitsuo ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Epidermal growth factor receptor tyrosine kinase inhibitor; Epithelial to mesenchymal transition; MET amplification

Indexed keywords

CARBOPLATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GEFITINIB; PEMETREXED; SCATTER FACTOR; UVOMORULIN; VIMENTIN;

AGED; ARTICLE; ATELECTASIS; AUTOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CASE REPORT; CELL PROLIFERATION; CHEST COMPUTED TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DRUG RESISTANCE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; EGFR GENE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; GIANT CELL; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG BIOPSY; MET GENE; TREATMENT DURATION; TUMOR BIOPSY; TUMOR RECURRENCE; VISCERAL PLEURAL NODULE BIOPSY;

EID: 84929416694     PISSN: 11786930     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S78911     Document Type: Article

References (5)

1. Sequist LV, Waltman BA, Dias-Santagata D, et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med. 2011;3(75):75ra26.
2. Yu HA, Riely GJ, Lovly CM. Therapeutic Strategies Utilized in the Setting of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors. Clin Cancer Res. 2014;20(23):5898–5907.
3. The Japan Lung Cancer Society [homepage on the Internet]. Japan: Japanese Clinical Practice Guideline for Lung Cancer. Available from: http://www.haigan.gr.jp/modules/guideline/index.php?content_id=3. Accessed August 1, 2013.
4. Cappuzzo F, Marchetti A, Skokan M, et al. Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. J Clin Oncol. 2009;27(10):1667–1674.
5. La Monica S, Caffarra C, Saccani F, et al. Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification. PLoS One. 2013;8(10):e78656.